LeMaitre Vascular - LMAT Stock Forecast, Price & News

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for LeMaitre Vascular in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" LMAT shares.
View LMAT analyst ratings or view top-rated stocks.

1 Wall Street research analysts have issued twelve-month target prices for LeMaitre Vascular's stock. Their LMAT share price forecasts range from $50.00 to $70.00. On average, they anticipate the company's stock price to reach $60.00 in the next year. This suggests a possible upside of 9.4% from the stock's current price.
View analysts price targets for LMAT or view top-rated stocks among Wall Street analysts.

LeMaitre Vascular's stock was trading at $50.23 at the beginning of 2022. Since then, LMAT shares have increased by 9.2% and is now trading at $54.85.
View the best growth stocks for 2022 here.

The company is scheduled to release its next quarterly earnings announcement on Thursday, October 27th 2022.
View our LMAT earnings forecast.

LeMaitre Vascular, Inc. (NASDAQ:LMAT) announced its quarterly earnings data on Thursday, October, 28th. The medical instruments supplier reported $0.30 earnings per share for the quarter, missing analysts' consensus estimates of $0.33 by $0.03. The medical instruments supplier earned $38.37 million during the quarter, compared to analysts' expectations of $39.05 million. LeMaitre Vascular had a trailing twelve-month return on equity of 9.86% and a net margin of 13.94%. LeMaitre Vascular's revenue was up 5.4% on a year-over-year basis. During the same quarter last year, the business posted $0.37 EPS.

LeMaitre Vascular declared a quarterly dividend on Tuesday, July 26th. Shareholders of record on Thursday, August 25th will be paid a dividend of $0.125 per share on Thursday, September 8th. This represents a $0.50 dividend on an annualized basis and a yield of 0.91%. The ex-dividend date of this dividend is Wednesday, August 24th.
Read our dividend analysis for LMAT.

LeMaitre Vascular (NASDAQ:LMAT) pays an annual dividend of $0.50 per share and currently has a dividend yield of 0.94%. The company has been increasing its dividend for 11 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 49.51%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, LMAT will have a dividend payout ratio of 37.59% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for LMAT.

LeMaitre Vascular updated its third quarter 2022 earnings guidance on Thursday, August, 4th. The company provided earnings per share (EPS) guidance of $0.24-$0.29 for the period, compared to the consensus EPS estimate of $0.31. The company issued revenue guidance of $39.00 million-$41.00 million, compared to the consensus revenue estimate of $40.16 million.

13 employees have rated LeMaitre Vascular Chief Executive Officer George W. LeMaitre on Glassdoor.com. George W. LeMaitre has an approval rating of 33% among the company's employees. This puts George W. LeMaitre in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other LeMaitre Vascular investors own include AbbVie (ABBV), Sociedad Química y Minera de Chile (SQM), Gilead Sciences (GILD), Aurora Cannabis (ACB), Aurora Cannabis (ACBFF), NVIDIA (NVDA), Adobe (ADBE), Boeing (BA) and Salesforce (CRM).

LeMaitre Vascular trades on the NASDAQ under the ticker symbol "LMAT."

LeMaitre Vascular's stock is owned by many different retail and institutional investors. Top institutional shareholders include Conestoga Capital Advisors LLC (8.45%), Copeland Capital Management LLC (5.52%), Geneva Capital Management LLC (3.90%), Russell Investments Group Ltd. (1.61%), Kennedy Capital Management Inc. (1.32%) and Rice Hall James & Associates LLC (1.22%). Insiders that own company stock include David B Roberts, George W Lemaitre, George W Lemaitre, John A Roush, Joseph P Pellegrino Jr, Lawrence J Jasinski and Trent G Kamke.
View institutional ownership trends.

Shares of LMAT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of LMAT stock can currently be purchased for approximately $54.85.

LeMaitre Vascular (NASDAQ:LMAT) has a market capitalization of $1.20 billion and generates $154.42 million in revenue each year. The medical instruments supplier earns $26.91 million in net income (profit) each year or $1.01 on an earnings per share basis.

The company employs 450 workers across the globe.

LeMaitre Vascular was founded in 1983.

LeMaitre Vascular's mailing address is 63 SECOND AVENUE, BURLINGTON MA, 01803. The official website for the company is www.lemaitre.com. The medical instruments supplier can be reached via phone at (781) 221-2266 or via fax at 781-425-5049.